Page 547 - IJB-10-2
P. 547

International Journal of Bioprinting                          Bottom-up and top-down VAT photopolimerization




            concentration: C2C12 and MSCs were mixed with (GelMA   the  printing  volume  was  determined  to  be  around  3  ×
            3% w/v and PEGDA 15% w/v), while HUVECs were mixed   3  × 3 cm. In the case of microfluidics bioprinting, the
            with (GelMA 5% w/v and PEGDA 15% w/v).             microfluidics working chamber has a diameter of 8 mm.

               As illustrated in  Figure 4, the fluorescence image   The lateral resolution (XY) of the DLP is in the order of 10
            revealed the capability of the system to print the spatially   microns, and the Z resolution of 20 nm can be achieved
            distributed cell-laden  bioinks,  laying  down  the basis   by the Thorlabs Z platform. To avoid cross-contamination
            for  future  fabrication  of  functional  multi-material   issues during the bioprinting process, we added a washing
            musculoskeletal tissues. The addition of more PEGDA   bath in between each material selection (the washing
            could result in more mechanical stability. It will make it   process is illustrated on Figure 1f). The process can easily
            easier to handle the tissue microenvironment fabrication.   be adapted for work with more than two materials by
            Still,  PEGDA  led  to  more  encapsulated  cell  toxicity;   flowing different biomaterials into the chip or by using
            indeed, 30%–40% v/v concentrations of PEGDA might   more biomaterials containers in the bottom-up and top-
            be inappropriate for biological components. The GelMA/  down approaches. However, it should be noted here that
            PEGDA bioink used in the microfluidics fabrication   careful selection of the final mechanical properties of the
            processes of the musculoskeletal environment, the   soft support is necessary, in order to avoid flow-induced
            proposed PI concentration, and the UV exposure were   delamination that could result in accelerated degradation
            found to be safe for the proposed cell bioink application.   as well as channel clogging. Examples of multi-material
                                                               printing were also presented showing structures made
            4. Discussion                                      with two discrete hard–soft parts, respectively (Figure
                                                               2c(i) and (iii)). Furthermore, a construct consisting of six
            Herein,  we  presented  a  novel  bioprinting  system,  which   soft and six hard alternating regions was fabricated (Figure
            facilitates the fabrication of multi-material constructs laden   2c(ii)). Those soft–hard material combinations could be
            with three different cell types, as a proof of concept for a   used in order to model bone-to-soft tissue interfaces [41,42] .
            musculoskeletal tissue model on-a-chip. The incorporation   Especially by combining more regions in one construct
            of a rotating mirror to the printing system allowed the fast   and controlling the mechanical properties of each region,
            switch between the bottom-up and top-down printing   tissue models consisting of more than two materials can be
            modes and the combination of both approaches on a single   fabricated, allowing the study of complex systems such as
            musculoskeletal junction model. As a future upgrade of the   the intervertebral disc regeneration .
                                                                                           [43]
            dual printer, a fully automated system could be developed,   The prepared bioinks were made from GelMA and
            in order to couple the movement of the stage with the mirror   PEGDA, due to their wide use in biofabrication applications
            rotation, thus further optimizing the fabrication time and   as well as their light responsiveness . By combining
                                                                                              [44]
            limiting the manual steps of the process. This modification   the  two  materials  in  different  concentrations  while  also
            could facilitate the implementation of the dual printer in   changing the concentration of the photoinitiator, we
            the mass production of a wide range of organs-on-chips   could get a compression modulus range from ~22 kPa to
            using the bottom-up, top-down, or combined processes.
                                                               ~870 kPa. The measured moduli showed an increase with
               The wide range of constructs that can be fabricated   both the GelMA and PEGDA concentrations when using
            using the dual-printing approach was highlighted   0.05% LAP. Interestingly, this trend was not the same when
            by the different geometries (Figure 2). Scaffolds with   the concentration of the photoinitiator was increased.
            interconnected  pores  and intricate  patterns  can  be   More precisely, PEGDA 15% mixed with 3% of GelMA
            generated using the bottom-up approach, providing   showed  an  increased  modulus  when  compared  to  the
            mechanical support as well as a suitable environment for   PEGDA 15%/GelMA 0% formulation. However, when the
            cells to grow . The top-down approach was used for the   concentration of GelMA was increased to 5%, the modulus
                      [40]
            fabrication of complex microvasculature patterns from   showed a decrease of approximately 32.5%. Furthermore,
            GelMA and PEGDA. On their own, these constructs can   the concentration increases of GelMA from 0% to 3% and
            be used as a soft support for vascularized tissue models,   subsequently to 5% resulted in a 27.6% and a further 8%
            and the generated channels can be used for the perfusion   modulus decrease when mixing with 35% PEGDA.
            of medium or other fluids. The maximum printing volume,
            which depends on the biomaterial container used, was   Most musculoskeletal diseases do not have a curative
            determined for each bioprinting configuration. The DLP   treatment yet. Some pathologies, such as amyotrophic
            can project over an area of 7 × 12 cm. Nevertheless, for   lateral sclerosis, Duchenne’s disease, or Lou Gehrig’s
                                                                                                    [45,46]
            the case of bottom-up and top-down approaches and   disease, still  do  not  have  real  treatment  .  Some
            for the proposed biomaterial container configuration,   treatments  for  more  common  chronic  diseases,  such  as
                                                               cholesterolemia and diabetes, also have unwanted muscle

            Volume 10 Issue 2 (2023)                       539                                doi: 10.36922/ijb.1017
   542   543   544   545   546   547   548   549   550   551   552